Organovo Holdings Inc. Daily Stock Analysis

Daily Stock Analysis, ONVO, Organovo Holdings Inc, priceseries

Organovo Holdings Inc. Daily Stock Analysis
Stock Information
Open
3.78
Close
3.86
High
4.25
Low
3.78
Previous Close
3.91
Daily Price Gain
-0.05
YTD High
4.67
YTD High Date
Mar 3, 2022
YTD Low
2.56
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.44
YTD Gain
-10.23%
52 Week High
12.14
52 Week High Date
Mar 10, 2021
52 Week Low
2.56
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-6.41
52 Week Gain
-62.41%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 17. 2018
22.60
Apr 19. 2018
24.10
2 Trading Days
6.64%
Link
LONG
May 9. 2018
24.20
Jun 1. 2018
34.36
16 Trading Days
41.99%
Link
LONG
Oct 31. 2019
6.06
Nov 13. 2019
7.42
9 Trading Days
22.40%
Link
LONG
Nov 14. 2019
7.68
Dec 9. 2019
9.33
16 Trading Days
21.46%
Link
LONG
Mar 24. 2020
5.04
Apr 1. 2020
5.93
6 Trading Days
17.58%
Link
LONG
Apr 24. 2020
7.32
May 14. 2020
12.12
14 Trading Days
65.67%
Link
LONG
May 21. 2020
14.40
May 26. 2020
15.14
2 Trading Days
5.13%
Link
LONG
Aug 3. 2020
14.11
Aug 6. 2020
14.86
3 Trading Days
5.28%
Link
LONG
Sep 29. 2020
7.32
Oct 1. 2020
7.89
2 Trading Days
7.83%
Link
LONG
Oct 5. 2020
7.44
Oct 19. 2020
9.03
10 Trading Days
21.42%
Link
LONG
Dec 17. 2020
7.95
Dec 29. 2020
11.99
7 Trading Days
50.85%
Link
LONG
Feb 5. 2021
14.93
Feb 16. 2021
17.46
6 Trading Days
16.93%
Link
Company Information
Stock Symbol
ONVO
Exchange
NasdaqGM
Company URL
http://www.organovo.com
Company Phone
858-550-9994
CEO
Taylor J. Crouch
Headquarters
California
Business Address
6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001497253
About

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.

Description

Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. It is developing a suite of standardized and three-dimensional human tissues for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion, and drug metabolism and pharmacokinetics; customized human tissues as living, dynamic models of human biology or disease for use in drug discovery and development; and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair, and functional tissue patches for the repair or replacement of damaged tissues and organs. The company has collaboration agreements with L'Oreal USA and Merck & Co. Organovo Holdings, Inc. was founded in 2007 and is headquartered in San Diego, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading